The company also announced a partnership with pharma giant Biogen that allows providers to submit enrollment forms for its multiple sclerosis drug Vumerity through the new platform.
The company also announced a partnership with pharma giant Biogen that allows providers to submit enrollment forms for its multiple sclerosis drug Vumerity through the new platform.